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Age at natural menopause may be used as parameter for evaluating the rate of ovarian aging. Environmental factors
determine only a small part of the large variation in menopausal age. Studies have shown that genetic factors are
likely to be involved in variation in menopausal age. To identify quantitative-trait loci for this trait, we performed
a genomewide linkage study with age at natural menopause as a continuous quantitative phenotype in Dutch sister
pairs, through use of a selective sampling scheme. A total of 165 families were ascertained using extreme selected
sampling and were genotyped for 417 markers. Data were analyzed by Haseman-Elston regression and by an
adjusted variance-components analysis. Subgroup analyses for early and late menopausal age were conducted by
Haseman-Elston regression. In the adjusted variance-components analysis, 12 chromosomes had a LOD score of
1.0. Two chromosomal regions showed suggestive linkage: 9q21.3 (LOD score 2.6) and Xp21.3 (LOD score 3.1).
Haseman-Elston regression showed rather similar locations of the peaks but yielded lower LOD scores. A per-
mutation test to obtain empirical P values resulted in a signiﬁcant peak on the X chromosome. To our knowledge,
this is the ﬁrst study to attempt to identify loci responsible for variability in menopausal age and in which several
chromosomal regions were identiﬁed with suggestive and signiﬁcant linkage. Although the ﬁnding of the region on
the X chromosome comes as no surprise, because of its widespread involvement in premature ovarian failure, the
deﬁnition of which particular gene is involved is of great interest. The region on chromosome 9 deserves further
consideration. Both ﬁndings require independent conﬁrmation.
Introduction
On average, women maintain optimal fertility until 30
years of age, after which fertility steadily decreases,
reaching 50% by age 35 years and approaching essen-
tially zero by age 41 years (Noord-Zaadstra et al. 1991).
This latter average is conﬁrmed by several studies, both
in industrialized populations and in populations that do
not use contraception, showing that the average mater-
nal age at birth of the last child is 41–42 years (Bongaarts
1982; Wood 1989). In many Western societies, during
the last 3 decades there has been an increasing delay in
childbearing. A major consequence of this trend is a
progressive inability to reproduce. In particular, women
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who exhibit early ovarian failure run the risk of invol-
untary infertility by delaying commencement of child-
bearing. It is has been suggested that the age at which
female infertility arises as a result of ovarian aging cor-
relates with the age at natural menopause (te Velde et
al. 1998) and, therefore, that variation in age at natural
menopause is a suitable parameter for assessing the rate
of ovarian aging.
The absence of any clear single causative environ-
mental factor to account for variation in the age of
menopause suggests a major involvement of genetic fac-
tors (Cramer et al. 1995b; van Noord et al. 1997). It
has been reported that common environmental factors
associated with age at menopause explain only a small
percentage of the total variation in menopausal age (van
Noord et al. 1997). Arguments in favor of the involve-
ment of genetic factors have been provided by several
studies. Family history has been shown to be a predictor
for early menopause (Cramer et al. 1995b), and a strong
association was found between mothers’ and daughters’
menopausal ages (Torgerson et al. 1997). Twin and fam-
ily studies have conﬁrmed a substantial genetic contri-
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bution to the variation in age at menopause. Snieder et
al. (1998) estimated a relative contribution of genetic
factors to the timing of natural menopause of 63% in
a large twin sample collected in the United Kingdom.
In an Australian twin sample, heritability was estimated
at 31%–53% (Treloar et al. 1998). In a study of a Dutch
population, heritability estimates of 70% and 85%
were reported in twin and sister pairs, respectively (de
Bruin et al. 2001).
In ∼1% of women, menopause occurs before age 40,
which is deﬁned arbitrarily as premature ovarian failure
(POF) (Coulam 1982; Coulam et al. 1986). Monoge-
netic causes are reported for a portion of the women
exhibiting POF (Aittomaki et al. 1996; Gromoll et al.
1996; Beau et al. 1998; Davison et al. 1998; Murray et
al. 1998; Allingham-Hawkins et al. 1999; Touraine et
al. 1999; Davis et al. 2000; Marozzi et al. 2000b; Cris-
poni et al. 2001; Doherty et al. 2002; Schlessinger et
al. 2002).
To date, however, the genes involved in the normal
range in menopause remain largely unclear. The only
gene variants reported so far to be associated with var-
iation in age of menopause are a noncoding polymor-
phism in the estrogen receptor 1 (a) (ER) gene and a
mutation in the factor V Leiden gene. The demonstrated
effect of the ER polymorphismwas small; homozygosity
for one of the two alleles reduced the age of menopause
by 1 year (Weel et al. 1999).Moreover, two independent
studies were unable to replicate this ﬁnding (Gorai et
al. 2003; H. S. Kok, N. C. Onland, K. M. van Asselt,
C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee,
and P. H. M. Peeters, unpublished data). Recently, we
have shown that the factor V Leiden mutation is as-
sociated with an earlier age at menopause (van Asselt
et al. 2003); women who were heterozygous for the
mutation had an onset of menopause that occurred 3
years earlier than in women without the mutation.
Given the large variation in menopausal age, the ab-
sence of clear common causative environmental factors,
and a high heritability, age at menopause meets all cri-
teria of a (quantitative) complex trait.
The amount of genotyping required to detect a locus
can be reduced considerably, with retention or improve-
ment of power, by selecting those sib pairs most likely
to show deviation from the expected proportion of allele
sharing. Pairs that are genetically informative for link-
age are those with concordant late or early age at men-
opause and discordant pairs in which one member has
an early menopause and the other a late menopause.
Each group has a different power to detect loci, de-
pending on the underlying genetic model, which is as
yet unknown and can only be assumed in power studies.
To identify susceptibility loci determining variation
in menopausal age, we performed the ﬁrst genomewide
linkage study of age at natural menopause as a con-
tinuous quantitative phenotype in Dutch sister pairs,
through use of a selective sampling scheme.
Methods
Phenotype and Inclusion Criteria
The phenotype, or trait, of interest is age at natural
menopause. We deﬁned “natural menopause” as pro-
posed by the World Health Organization (World Health
Organisation Scientiﬁc Group 1996)—namely, as 12
consecutive months of amenorrhea not due to surgery
or other obvious causes. Accordingly, women who were
premenopausal at the time of hysterectomy or either bi-
lateral or unilateral ovariectomy were not considered
eligible as probands; unilateral ovariectomy was re-
garded as an exclusion criterion, because it is known to
be associated with an earlier age at menopause (Cramer
et al. 1995a; Melica et al. 1995; Hardy and Kuh 1999).
Women who had started using oral contraceptives (OCs)
or hormonal replacement therapy (HRT) within 1 year
after their last period were also considered ineligible,
since age at menopause cannot be determined with cer-
tainty in such cases.
In QTL analysis, power can be increased considerably
by sampling sib pairs with phenotypic values in the ex-
treme parts of the trait distribution (Risch and Zhang
1995). Accordingly, we aimed to restrict our sampling
to female sib pairs with menopausal ages of 45 years
and/or 54 years (corresponding to the 12.5th percen-
tiles of the distribution of age at menopause). When
possible, the parents or additional sisters or brothers
were included, to reconstruct the missing parental ge-
notypes for phase determination.
Family Ascertainment
We used several strategies to ascertain families. Two
large-scale population-based cohorts, the Diagnostisch
Onderzoek Mammacarcinoom (DOM) and Prospect-
EPIC cohorts, were used to identify possible probands.
The design and sampling strategy of these cohorts have
been described in detail elsewhere (de Waard et al. 1984;
Boker et al. 2001). In brief, both cohorts consist of
women who were invited to join the respective studies
through an existing regional population-based program
of breast cancer screening. For these two cohorts, in-
formation on menopausal age and whether or not
menopause had occurred naturally was available for
∼40,000 women in the region of Utrecht. Probands ful-
ﬁlling the inclusion criteria were approached, and in-
quiries were made about the presence of sisters and, if
alive, about their menopausal status. Probands were sent
pedigree forms to provide information on family struc-
ture and menopausal status of sister(s). Physicians clar-
iﬁed apparent inconsistencies in the data through a tel-
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ephone call. If at least two sisters complied with the
inclusion criteria, the family was asked to participate.
Blood samples (20 ml of EDTA-treated blood) were
taken, and female participants were requested to ﬁll out
a questionnaire on reproductive history. A total of 126
families was included through use of these cohorts. Fur-
ther, through press releases in a newspaper, women’s
magazines, the Dutch Twin Registry, and outpatient clin-
ics of the University Medical Center in Utrecht and Nij-
megen, 39 additional families were included. In total,
information and DNA from 583 individuals from 165
families was collected. The institutional review board of
the University Medical Center Utrecht approved the
study protocol. Written informed consent was obtained
from all participants.
From the questionnaire data, age at start and stop of
HRT, age at start and stop of OC use, age at hysterectomy
and/or ovariectomy, and age at ﬁnal cessation of men-
struation were obtained. It was decided that, in speciﬁc
situations, age at menopause might be determined with
some degree of acceptable uncertainty in the case of ad-
ditional sisters only: (a) women who stopped using OCs
at age 45 years and had no periods after that were
assigned a menopausal age of 1 year earlier ( ); (b)n p 16
women who had a hysterectomy or bilateral ovariectomy
at age 54 years and were still premenopausal at that
time were assigned a menopausal age of 1 year later
( ); (c) women who were aged 54 years at ascer-n p 7
tainment and were still premenopausal were assigned a
menopausal age of 1 year later ( ); (d) for womenn p 7
who reported starting HRT 1 year later than their men-
opausal age, it remained uncertain whether 12 mo of
amenorrhea had passed ( ), and therefore reportedn p 11
age at last menstruation was accepted as menopausal age;
and (e) for women aged 154 years for whom the age of
starting HRT was equal to the age of last menstruation,
menopausal age was assigned to be the age at whichHRT
was started ( ). In 88% of women, age at naturaln p 10
menopause was unambiguously determined.
Genotyping
DNA was extracted from peripheral blood lympho-
cytes by high salt extraction (Miller et al. 1988). DNA
concentration was measured with a spectrophotometer
(Tecan), and samples were diluted with distilled water
to a concentration of 15 ng/ml. The DNA samples were
divided into 96-well microtiter plates. Every DNA plate
contained as many as 86 unique DNA samples, 6 blind
duplicate samples, 3 CEPH controls, and 1 negative
control.
The Mammalian Genotyping Service of the Marsh-
ﬁeld Medical Research Foundation performed the ge-
notyping for the initial screen. The marker set was based
on Marshﬁeld Screening Set 11 and consisted of 408
polymorphic microsatellite markers with an average
spacing of 10 cM and an average heterozygosity of 0.75.
Genotypes with a reported Marshﬁeld quality score
!0.99 were recoded as unknown. Six markers located
on the Y chromosome were excluded from all analyses.
Fifteen additional markers were used to increase the
information content for some chromosomal regions.
Marker positions in these regions were veriﬁed using the
Ensembl and Decode databases (Kong et al. 2002). Ei-
ther the forward or the reverse oligonucleotide primer
was labeled with 6-FAM, HEX, or NED ﬂuorescent dyes
(Biolegio and Applied Biosystems). PCRs were per-
formed in a 10-ml volume containing 30 ng of template
DNA, 25 ng of each oligonucleotide primer, 200 mM
of each dNTP, and 0.4 U AmpliTaq Gold (Applied Bio-
systems), in 1# PCR buffer II with 2.5 mM MgCl2 (Ap-
plied Biosystems). DNA was initially denatured at 94C
for 7 min and was then subjected to 33 cycles of 94C
for 30 s, 55C for 30 s, and 72C for 30 s, followed by
a ﬁnal extension step of 30 min at 72C. PCR products
were diluted four times with distilled water, and 1 ml of
diluted product was mixed with 4 ml of HiDi (Applied
Biosystems) and 0.1 ml of GS-500 size standard (Applied
Biosystems) and was separated in POP6 polymer on an
ABI 3700 capillary DNA sequencer (Applied Biosys-
tems). Data were analyzed using Genescan 3.6 and Ge-
notyper 3.5 forWindows NT (Applied Biosystems). Two
independent raters genotyped the additional markers
and checked results for inconsistency. If they disagreed,
the genotypes were set to unknown.
Study Subjects
Relationships between siblings were veriﬁed using the
program GRR (Abecasis et al. 2001). This resulted in
the identiﬁcation of three half sibs and one MZ twin
pair. The three half sibs were excluded, as was one sister
from the MZ twin pair.
In total, 579 individuals from 165 families were in-
cluded in the ﬁnal study population. Four hundred thirty-
one women met the inclusion criteria and were assigned
a phenotypic value; the remaining individuals were par-
ents, brothers, and sisters included for additional phase
information. Inheritancewithin familieswas veriﬁedusing
the Pedcheck program (O’Connell and Weeks 1998). If
there were apparent inheritance errors due to presumptive
mistyping or misidentiﬁcation, the complete family was
excluded from the analysis for that speciﬁc marker. Allele
frequencies were calculated from all available genotypes.
Statistical Analysis
Two methods were applied to analyze the data; the
original Haseman-Elston regression method and a var-
iation of the variance-components (VC) method. Non-
normality of the data as a result of the extreme sampling
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Figure 1 Histogram of age at menopause of women included in the VC analyses
scheme requires special attention in the analyses. Al-
though the Haseman-Elston regression analysis is robust
to deviations from normality (Haseman and Elston
1972), it exhibits loss of power in this study design, since
it depends strongly on the magnitude of the phenotypic
difference of a sib pair, which is, by deﬁnition, small in
extremely concordant sib pairs. Single- and multipoint
LOD scores were computed by the Mapmaker/Sibs pro-
gram (Kruglyak and Lander 1995), using all possible
distinct pairs.
Since standard VC QTL analysis is susceptible to non-
random ascertainment, we used a modiﬁcation of the
likelihood function by correcting for the ascertainment
bias introduced by the extreme sampling (see, e.g., Mor-
ton [1959]); the likelihood function is shown in the ap-
pendix. For this analysis, identity-by-descent (IBD) prob-
abilities, as derived from the Mapmaker/Sibs program
(Kruglyak and Lander 1995), were used.
For chromosomes with suggestive evidence for link-
age, we performed simulations to obtain signiﬁcance
thresholds. Empirical P values were obtained by per-
muting the IBD probabilities over the sib pairs. A ge-
nomewide P value !.05 was considered to be of ge-
nomewide signiﬁcance.
The mean and SD of menopausal age were estimated
from a population-based study, Prospect-EPIC, andwere
50.2 years and 4.2 years, respectively. Since smoking
status at menopause was available for all sib pairs,
an analysis with this information as a covariate was
performed.
Figure 1 shows the distribution of age at menopause
in the study population. Although participants were es-
sentially sampled from extremes of the distribution, it
turned out that some women had experienced natural
menopause at a less extreme age. The ages at menopause
of these women were also included in the Haseman-
Elston analyses because, although relatively few in num-
ber, they expanded the range of phenotypic variation
being analyzed. However, the trait values of these
women could not be included in the adjusted VC anal-
yses without caution, because, in this model, the like-
lihood is divided by the probability that a particular
family is selected. Therefore, the ascertainment scheme
requires clear cutoff points, and a family was included
only when it contained at least two sisters with meno-
pausal ages in the 12.5th percentiles. Therefore, in this
analysis, women with menopausal ages outside the ex-
tremes participated only when they had at least two
sisters who met the strict inclusion criteria. Of the 165
available families, 130 families were included in the ad-
justed VC analysis.
The overall information content of the markers was
obtained by calculating the average multipoint infor-
mation content for all markers.
Subgroup Analyses
Separate analyses for families with a late menopausal
age and those with an early menopausal age were con-
ducted. The following criteria were applied to construct
the respective subgroups of early and late menopausal
sib pairs used for the Haseman-Elston regression. Sib
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Table 1
Number of Phenotyped and Genotyped Families
SIBSHIP SIZE
NO. OF FAMILIES
All
Late
Menopause
Early
Menopause
No. of phenotyped
women per family:
2 99 46 57
3 42 20 27
4 14 8 7
5 9 5 5
6 1 1 0
Total 165 80 96
No. of genotyped
individuals per family:
2 39 19 23
3 50 23 31
4 46 23 25
5 19 10 9
6 8 4 6
7 2 1 1
10 1 0 1
Total 165 80 96
Table 2
Characteristics of the 431 Phenotyped Women
Characteristic Value Range or %
Mean age at inclusion (in years) 62 26–86
Median time since menopause (in years) 12 0–46
Median no. of offspring 2 0–15
No. nulliparous 54 12.5%
No. with 1 miscarriage 103 23.9%
No. with 2 miscarriages 32 7.4%
No. who have ever smoked 117 27.1%
No. who have ever used OCs 244 56.6%
No. who have ever used HRT 73 16.9%
pairs were included in the “early group” when at least
one sister had a menopausal age of 45 years. For a sib
pair to be included in the “late group,” one sister needed
to have a menopausal age of 54 years. These criteria
resulted in a sampling overlap between the groups—that
is, 11 sib pairs were included in both groups.
Results
Sample Characteristics
In table 1, an overview is given of the numbers of
families per size of the phenotyped and genotyped sib-
ships for the total study population, as well as for the
respective subgroups. In table 2, characteristics of the
phenotyped women are given. The study subjects had a
mean age of 62 years (range 26–86 years) at inclusion
in the present study.
Genotype Characteristics
For the initial screen, the overall genotype error rate
was 0.2%, and the average genotyping completenesswas
98.5%. When the 15 additionally typed markers were
included, the average marker information content across
the genome was 0.68.
Haseman-Elston and VC Analyses
Table 3 shows the locations where linkage signalswere
found by the VC with LOD scores 1. In ﬁgure 2, for
each chromosome, the multipoint LOD scores obtained
by Haseman-Elston regression and the VC model are
plotted in one graph. Overall, the VC analyses yielded
higher LOD scores than did the Haseman-Elston re-
gression. However, the genome positions of the peaks
are rather similar, implying that both methods generally
agree on the location but differ in the signiﬁcance of the
observation.
Two regions showed suggestive linkage. On chro-
mosome 9, region 9q21.3, a LOD score of 2.6 was ob-
tained by the VC analysis. The second region with sug-
gestive linkage was located on the X chromosome, with
the highest LOD score of 3.1 on Xp21.3. The marker
information content at the peaks on chromosome 9 and
X were 82% and 84%, respectively. The proportion of
the total variance present in the study group explained
by the QTL on chromosome region 9q21.3 was 24%,
and the proportion explained by that on chromosome
region Xp21.3 was 30%. Incorporating smoking atmen-
opause as a covariate in the model did not further in-
crease the peaks on chromosome 9 and X.
Empirical Signiﬁcance Thresholds
Permutation tests for chromosomes 9 and X were per-
formed to assess signiﬁcance of the adjusted VC analysis.
We performed 1,000 simulations for both chromosomes
X and 9. A Bonferroni correction was used to approx-
imate genomewide signiﬁcance levels. This may not be
entirely appropriate, since the chromosomes differ in
length; however, it was computationally unfeasible to
perform genomewide simulations. Sincemarker spacings
were consistent throughout the genome, and since chro-
mosomes 9 and X are slightly above average in length,
it is expected that the Bonferroni correction will be con-
servative rather than liberal.
The chromosomewide P value of the highest peak on
chromosome 9 is .005; when the Bonferroni correction
is used, this implies a genomewide P value of .115. For
the X chromosome, the chromosomewide P value is
.001, and the genomewide P value is .023.
Subgroup Analyses
Two subgroups—early menopause (96 families) and
late menopause (80 families)—were analyzed by the
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Table 3
Regions with Multipoint LOD
Scores 1 by Adjusted VC
Analyses
Chromosome and
Position (in cM)
LOD
Score P
2:
125 1.3 .0072
3:
121 1.8 .0020
210 1.6 .0033
6:
142 1.4 .0056
9:
80 2.6 .0003
99 2.0 .0012
11:
135 1.6 .0033
12:
50 1.0 .0159
13:
79 1.0 .0159
15:
42 1.0 .0159
17:
9 1.7 .0026
18 1.6 .0033
19:
1 1.4 .0056
90 1.0 .0159
22:
27 1.5 .0043
X:
35 3.1 .0001
85 2.1 .0009
129 1.4 .0051
Haseman-Elston regression. In general, the Haseman-
Elston regression analyses conducted with subgroups re-
sulted in higher LOD scores than those obtained using
all sib pairs. Figure 3 displays the results of the subgroup
analyses for chromosomes 9 and X. For chromosome 9,
the peak found in the overall group was increased when
only the women with late menopause were analyzed,
although both groups supported the linkage. On the
other hand, the peak at Xp21.3 was almost entirely due
to the women with early menopause.
Discussion
We present results from the ﬁrst genomewide scan for
QTLs inﬂuencing menopausal age. Our analysis iden-
tiﬁed two regions, on chromosomes 9 and X, with LOD
scores of 2.6 and 3.1, respectively. Empirical signiﬁcance
thresholds indicated that the peak on X chromosome
is signiﬁcant and that the peak on chromosome 9 is
suggestive.
Previously, so-called “POF regions” on the X chro-
mosome have been described (Sala et al. 1997; Marozzi
et al. 2000a; Schlessinger et al. 2002), and the peak
found in our sample is located in such a region. The
subgroup analyses showed that the linkage found on
the X chromosome was entirely due to the women with
early menopausal ages. To establish whether it is likely
that the peak is based only on women with extremely
early menopause, we excluded women who would be
classiﬁed as having POF according to the most widely
used criterion, age at menopause of40 years (Coulam
et al. 1986). Exclusion of those women resulted in a
loss of 11 families. Although the LOD score of the peak
on chromosome X dropped (LOD 2.2 on 35 cM), sug-
gestive linkage remained. This indicates that linkage in
this region is not based only on women with POF, and,
stated otherwise, that the “POF region” is important
not only for POF but possibly also for “early meno-
pause.” The lower LOD score obtained after excluding
women with POF may simply reﬂect loss of power by
reducing the number of families. This hypothesis is sup-
ported by the observation that early menopause and
POF sometimes segregate within the same families (Ti-
biletti et al. 1999; Vegetti et al. 2000), and it may be
unrealistic to assume that POF and early menopause
should be regarded as completely distinct entities.
The region suggestive for linkage on chromosome 9
contains many genes. One of the genes in this region
encodes for the BCL2 family, a protein involved in ap-
optosis. This is interesting, because apoptosis is themost
common fate of the follicles in the ovaries, and the size
of the follicle pool is associated with menopausal age
(Hsueh et al. 1994; Billig et al. 1996; Kaipia and Hsueh
1997). Polymorphisms of BCL2 that are known tomod-
ulate the rate of human ovarian aging have not yet been
described.
The two genes for which association with humanmen-
opausal age has been reported, the ER gene (chromosome
6) and the factor V Leiden polymorphism (chromosome
1), are not located in any of the regions identiﬁed with
linkage in this study. The speciﬁc variances of these loci
may be too low to be detected by linkage in the present
study, with the low allele frequency of factor V Leiden
(∼0.04) and the low phenotypic impact of the ER poly-
morphism being likely explanations. The power analyses
(van Asselt and Kok 2003) have shown that loci with an
explained variance of 20% linkage could be detected
with a probability of 80%.
One must keep in mind that a joint estimation of the
location of genes and the estimation of their effect on
the phenotype (the variance explained by the QTL) in-
ﬂates the estimate of the variance attributable to each
QTL (Go¨ring et al. 2001). This is caused by the fact
that the statistic—which provides evidence for the pres-
ence of a locus at a given chromosomal location and is
typically given in the form of a LOD sore—is itself a
function of the parameters characterizing the genotype-
Figure 2 LOD score graphs of all chromosomes. LOD scores are shown on the Y-axis, and positions in centimorgans are shown on the
X-axis.
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Figure 3 LOD score graphs of subgroup analyses of chromo-
some 9 and X by Haseman-Elston regression. LOD scores are shown
on the Y-axis, and positions in centimorgans are shown on the X-axis.
phenotype relationship. Statistical signiﬁcance and the
derived parameters, therefore, are not independent and
are highly correlated. The extent of the bias depends
on the true parameter value, sample size, and study
design. The only realistic option for bias elimination
appears to be the use of independent data sets for locus
mapping and for estimation of the locus-effect size.
Moreover, the explained variance in a selected sample
cannot be extrapolated to a valid estimate in the pop-
ulation. Therefore, in the present study, we are unable
to determine what proportion of the total variation in
age at menopause is explained by the two detected
QTLs.
Phenotype deﬁnition is a critical issue for genetic in-
vestigations of complex human traits. Age at natural
menopause can be assessed only in retrospect, after a
period of 12 mo of amenorrhea. Misclassiﬁcation due
to year preference is a phenomenon known to occur
after some time (Hahn et al. 1997). However, the va-
lidity of self-reported menopausal age increases as the
extremes are approached (den Tonkelaar 1997). There-
fore, it is likely that, in a sample selected for extreme
values, the degree of misclassiﬁcation is low.
The use of sib pairs with extreme concordant or dis-
cordant trait values has some implications for the anal-
yses. First, the resulting trait distribution is obviously
very different from that present in the source popula-
tion, resulting in an overestimation of the prevalence of
extreme values of menopausal age, a possibly unrepre-
sentative mean value, and a highly distorted variance
estimate. Accordingly, the VC analysis was performed
with the mean and variance estimates derived from the
Prospect-EPIC study, a population-based cohort.
In a sensitivity analysis, we set out to assess the impact
of assigning different values for the mean and SD in an
adjusted VC analysis, tested on the marker genotypes
generated for chromosome 9. An increase of the mean
menopausal age by 2% (1 year) resulted in a 4% higher
LOD score. An equal decrease resulted in a 6% lower
LOD score. Varying the SD of the menopausal age
yielded the following results: a 25% increase in SD (∼1
year) resulted in a 21% lower LOD score, and a 25%
decrease (1 year) led to a 50% higher LOD score. This
is reassuring because, when errors of this magnitude in
the parameters are allowed for, suggestive linkage is still
reached.
Subgroup analyses of women with either a very early
menopause or a very late menopause have been per-
formed by Haseman-Elston regression. Unfortunately,
these subgroup analyses were not possible with the ad-
justed VC analyses. The ascertainment correction is sen-
sitive to the assumption of normality of the menopausal
ages in the population from which they were sampled.
The smaller the selection made, the more sensitive the
results of the adjusted VC analysis will be. Both sub-
groups supported the peak on chromosome 9. It is dif-
ﬁcult to disentangle whether a QTL would be an “in-
creaser” or “decreaser” when judged by which subgroup
produces the highest LOD score. The reason for this is
that a LOD score depends on the number of families and
on the spread of menopausal age, and these are not the
same for both groups.
To our knowledge, this is the ﬁrst attempt to identify
loci responsible for the variability of menopausal age
and in which several chromosomal regions were iden-
tiﬁed with suggestive linkage. Although the involvement
of the X chromosome comes as no surprise, when we
consider its widespread involvement in premature ovar-
ian failure, deﬁning which particular gene is involved
is of great interest. The region on chromosome 9 de-
serves further consideration. Both ﬁndings require in-
dependent conﬁrmation.
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Appendix
The log likelihood, corrected for ascertainment, for a
sibship of size m is given by ,1 p log [J (y)] log (Pr )m m
where
m[ ] ( )log J (y) p log (2p) 0.5 log det S[ ]m 2
T 10.5(y m) S (y m) .
Here, y denotes the m vector of menopause ages of the
family members, and Jm(y) is the m-variate normal den-
sity with mean vector m and covariance matrix S. The
covariance matrix is given by ,2 2m#m S p j  p jij s ij g
for , where is the variance due to shared envi-2i ( j js
ronment (common environment plus half of additive
polygenic variance), is the variance due to the QTL,2jg
and pij is the IBD value. The ascertainment correction,
Prm, is the probability that at least two sibs are in the
sampling region R, with age at menopause !46 years or
153 years; for , this equalsm p 2
Pr p J (y ,y )dy dy .2  2 1 2 1 2
R R
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